Diagnostic-therapeutic algorithm for thrombotic microangiopathy. A report of two cases

R Rubio-Haro1, M Quesada-Carrascosa1, J Hernández-Laforet1

  • 1Servicio de Anestesiología, Reanimación y Tratamiento del Dolor, Consorcio Hospital General Universitario, Valencia, Spain.

Insights

Thrombotic microangiopathies (TMA) are serious conditions causing anemia, low platelets, and organ damage. This article details two TMA cases: thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (aHUS).

Area of Science:

  • Hematology
  • Nephrology
  • Neurology

Background:

  • Thrombotic microangiopathies (TMA) are critical hematologic disorders characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
  • Prompt diagnosis and management of TMA are vital due to high morbidity and mortality rates.

Observation:

  • This report presents two distinct cases of TMA.
  • Case 1 involves a patient diagnosed with thrombotic thrombocytopenic purpura (TTP).
  • Case 2 involves a patient diagnosed with atypical hemolytic uremic syndrome (aHUS).

Findings:

  • The cases highlight the diverse clinical presentations of TMA.
  • Thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (aHUS) represent distinct TMA subtypes.
  • Both TTP and aHUS necessitate timely and accurate diagnostic approaches.

Implications:

  • Understanding TTP and aHUS is crucial for effective clinical management.
  • Early recognition of TMA syndromes can improve patient outcomes.
  • This case series underscores the importance of differentiating between TTP and aHUS for appropriate therapeutic strategies.